Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 0 Oropharyngeal Cancer”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT02855723
What this trial is testing

Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable

Who this might be right for
Head and Neck Tumors
University Hospital, Montpellier 307
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00012168
What this trial is testing

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Early research (Phase 1)Study completedNCT00978081
What this trial is testing

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Who this might be right for
Head and Neck CancerPrecancerous Condition
Abramson Cancer Center at Penn Medicine 35
Large-scale testing (Phase 3)Study completedNCT00008398
What this trial is testing

Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06532279
What this trial is testing

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more
NRG Oncology
Testing effectiveness (Phase 2)Ended earlyNCT02917629
What this trial is testing

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Who this might be right for
Oral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7+11 more
National Cancer Institute (NCI) 6
Very early researchEnded earlyNCT04630353
What this trial is testing

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Who this might be right for
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
Hookipa Biotech GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00002964
What this trial is testing

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00064103
What this trial is testing

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

Who this might be right for
Lip and Oral Cavity CancerOropharyngeal CancerStage 0 Lip and Oral Cavity Cancer+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT01469429
What this trial is testing

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more
Ohio State University Comprehensive Cancer Center 70
98